Exonin Tablets (Eperisone Hydrochloride)

Adult dose

As eperisone hydrochloride, administer 50㎎ orally three times a day after meals. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be administered to patients with hypersensitivity to this drug or to those with severe myasthenia gravis. Caution is advised for patients with a history of hypersensitivity to any drugs or with impaired liver function, and for those who have allergic reactions to Yellow No. 4 (tartrazine) included in this medication. During administration, shock reactions may rarely occur; symptoms should be closely monitored, and if any abnormal signs arise, discontinue the medication immediately and seek appropriate treatment. As this medication may affect liver or kidney function, treatment should be stopped and appropriate action taken if any abnormalities are found in liver tests or kidney function tests. Signs of hypersensitivity such as anemia, rash, and itching may also occur, so careful monitoring is required. Neurological symptoms such as insomnia, drowsiness, headache, limb paralysis, rigidity, or tremors may occur; report any unusual symptoms immediately. Gastrointestinal symptoms including nausea, vomiting, loss of appetite, abdominal pain, and diarrhea may also occur; if discomfort persists, consult with a medical professional. Urinary issues may arise, so be cautious if there are any abnormalities in urination. General symptoms such as weakness, dizziness, and general malaise have also been reported; monitor overall health carefully. Rarely, symptoms such as facial flushing, sweating, and swelling may present. Severe cutaneous adverse reactions, such as toxic epidermal necrolysis syndrome, may present with fever, erythema, blisters, itching, conjunctival injection, and stomatitis; if these symptoms occur, discontinue the medication immediately and inform a healthcare provider. Experiencing drowsiness or decreased attention while taking this medication may occur, thus it is advisable to avoid driving or operating hazardous machinery. Avoid taking this medication in conjunction with other drugs containing similar components as it may cause issues with vision correction. Pregnant women or those who may become pregnant should exercise caution as the safety of this medication has not been established; consult a physician before use. Nursing mothers should avoid using this medication; if it is unavoidable, it is advisable to stop breastfeeding temporarily. Caution is necessary for use in pediatric patients as safety has not been sufficiently confirmed. Elderly patients may have reduced bodily functions, thus special care with dosage adjustments may be necessary.

Serious side effects

• Shock
• increased ALT
• increased AST
• increased ALP
• proteinuria
• increased BUN
• anemia
• anaphylactic reactions
• angioedema
• toxic epidermal necrolysis

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• limb paralysis
• rigidity of the body
• tremors
• nausea
• vomiting

This medication should be stored in a tightly sealed container to prevent air and moisture exposure, and it is best preserved at room temperature that is neither too hot nor too cold. This helps maintain the medication's efficacy over time.

Appearance

White round coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle